(Q28375647)
Statements
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin (English)
G W McCaughan
J Spencer
D Koorey
S Bowden
A Bartholomeusz
D Verran
A K Chui
A G Sheil
R M Jones
S A Locarnini